Neumora makes corporate presentation available at J.P. Morgan Healthcare Conference

Neumora Therapeutics, Inc.

Presentation furnished as Exhibit 99.1; no financial or pipeline specifics provided in the filing text.
Company plans to use presentation for investor and analyst meetings at 42nd Annual J.P. Morgan Healthcare Conference.
No new material disclosures beyond availability of the presentation were included in the 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.